Renin-Angiotensin-Aldosterone System Inhibitors and the Risk of AKI in COVID-19 Compared with Influenza

Clin J Am Soc Nephrol. 2022 Mar;17(3):423-425. doi: 10.2215/CJN.11190821. Epub 2022 Feb 2.
No abstract available

Keywords: ACE inhibitors; COVID-19; acute kidney injury; renin-angiotensin system.

Publication types

  • Comparative Study
  • Letter
  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, Non-P.H.S.

MeSH terms

  • Acute Kidney Injury / chemically induced
  • Acute Kidney Injury / epidemiology*
  • Acute Kidney Injury / virology
  • Angiotensin Receptor Antagonists / adverse effects*
  • Angiotensin-Converting Enzyme Inhibitors / adverse effects*
  • COVID-19 / epidemiology*
  • COVID-19 / virology
  • Humans
  • Incidence
  • Influenza, Human / epidemiology*
  • Influenza, Human / virology
  • Renin-Angiotensin System / drug effects*
  • Risk Assessment
  • Risk Factors
  • Time Factors
  • United States / epidemiology
  • Veterans

Substances

  • Angiotensin Receptor Antagonists
  • Angiotensin-Converting Enzyme Inhibitors